Table 1.
Correlation between the expression of BAP31 and clinicopathological parameters in HCC.
| Characteristics | BAP31 low expression | BAP31 high expression | P | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Gender | 0.257 | ||||
| Male | 93 | 76.2 | 88 | 69.8 | |
| Female | 29 | 23.8 | 38 | 30.2 | |
| Age (years) | 0.545 | ||||
| ≤50 | 55 | 45.1 | 52 | 41.3 | |
| >50 | 67 | 54.9 | 74 | 58.7 | |
| Tumor size | 0.002* | ||||
| T1 or T2 | 48 | 39.3 | 27 | 21.4 | |
| T3 or T4 | 74 | 60.7 | 99 | 78.6 | |
| Lymph node | <0.0001* | ||||
| N0 | 107 | 87.7 | 80 | 63.5 | |
| N1 | 15 | 12.3 | 46 | 36.5 | |
| Grade | 0.461 | ||||
| – | 9 | 7.4 | 12 | 9.5 | |
| 1 | 5 | 4.1 | 9 | 7.2 | |
| 2 or 3 | 108 | 88.5 | 105 | 83.3 | |
| Stage | <0.0001* | ||||
| I or II | 65 | 53.2 | 28 | 22.2 | |
| III or IV | 57 | 46.7 | 98 | 77.8 | |
*
Statistically significant.